OGD celebrates over a thousand approvals

More than a thousand generics received either a final or tentative approval from the US Food and Drug Administration (FDA) in 2017, according to the Office of Generic Drugs (OGD) annual report that has just been published by the regulator.

More from Regulation

More from Policy & Regulation